2018
![](https://www.farmaindustriaticino.ch/files/2016/07/logo-cerbios-FIT-Farma-Industria-300x300-1-160x160.png)
Lipidor: First Patient In for Phase III trials of new high- comfort, high-control anti-psoriasis spray
![](https://www.farmaindustriaticino.ch/files/2016/07/logo-cerbios-FIT-Farma-Industria-300x300-1-160x160.png)
CERBIOS AND IRB COLLABORATE ON DEVELOPING ANTIBODIES TARGETED AT LEUKEMIA CELLS
La bilancia commerciale ticinese – L’export cantonale nel 2017
PKU GOLIKE debuts at SSIEM 2018 Conference: science driven innovation behind the medical food for PKU management of APR Applied Pharma Research
![](https://www.farmaindustriaticino.ch/files/2018/09/IMG_4602-1-160x160.jpg)
Farma Industria Ticino and Credit Suisse Award for best student
![](https://www.farmaindustriaticino.ch/files/2018/06/IMG_4846-160x160.jpg)
38a Assemblea generale ordinaria di FIT
Swissmedic – informativa speciale OATer IV
Linnea obtained the Certificate of Suitability (CEP) for hyoscine butylbromide released by EDQM
![](https://www.farmaindustriaticino.ch/files/2018/05/analysis-2030266_1920-160x160.jpg)
Linkedin